IMUX: Nagel Robert Thorvald discloses securities transactions

By AlphaYouPublished Sep 19, 2026Form 4

Stocks in this disclosure

Reported activity

Nagel Robert Thorvald

Reporting filer

Nagel Robert Thorvald reported Grant or award in IMMUNIC, INC.: 25370 units of Stock Option (derivative), dated 2026-09-16. The full Form 4 contains 1 transaction entry.

Disclosed: Sep 19, 2026

Reported details

1 entry

All validated entries in this disclosure
Security	Owner	Date	Code	Action	Quantity	Price	Following holdings	Reporting delay	Filed terms and references
Stock Option (derivative)	Nagel Robert Thorvald	2026-09-16	A	Grant or award	25370	0.00	25,370	3 days	Filed terms security Title: Stock Option conversion Or Exercise Price: 10.12 transaction Date: 2026-09-16 deemed Execution Date: transaction Form Type: 4 transaction Code: A equity Swap Involved: 0 transaction Timeliness: transaction Shares: 25370 transaction Price Per Share: 0.00 transaction Acquired Disposed Code: A id: F1 expiration Date: 2036-09-16 underlying Security Title: Common Stock underlying Security Shares: 25370 shares Owned Following Transaction: 25370 direct Or Indirect Ownership: D id: F2

Stock Option (derivative)

Owner: Nagel Robert Thorvald
Date: 2026-09-16
Code: A
Action: Grant or award
Quantity: 25370
Price: 0.00
Following holdings: 25,370
Reporting delay: 3 days
Filed terms and references: Filed terms
security Title: Stock Option
conversion Or Exercise Price: 10.12
transaction Date: 2026-09-16
deemed Execution Date:
transaction Form Type: 4
transaction Code: A
equity Swap Involved: 0
transaction Timeliness:
transaction Shares: 25370
transaction Price Per Share: 0.00
transaction Acquired Disposed Code: A
id: F1
expiration Date: 2036-09-16
underlying Security Title: Common Stock
underlying Security Shares: 25370
shares Owned Following Transaction: 25370
direct Or Indirect Ownership: D
id: F2

Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.

Filing context

Quantities and prices are shown in the units filed. No trade value is inferred from their product.
Nagel Robert Thorvald: Director.
F1: The option vests in monthly increments over a period of one year from the grant date.
F2: The Reporting Person is a member of BVF Partners L.P. ("BVF") and is obligated to transfer the economic benefit, if any, received upon the sale of the shares issuable upon exercise of the equity grants to BVF. As such, the Reporting Person disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of his pecuniary interest therein, if any.

Original sources

SEC ownership filing

Prepared automatically from public filing data. Report a correction.

Security

Owner

Date

Code

Action

Quantity

Price

Following holdings

Reporting delay

Filed terms and references

Stock Option (derivative)

Nagel Robert Thorvald

2026-09-16

Grant or award

25370

0.00

25,370

3 days

Filed terms

security Title: Stock Option
conversion Or Exercise Price: 10.12
transaction Date: 2026-09-16
deemed Execution Date:
transaction Form Type: 4
transaction Code: A
equity Swap Involved: 0
transaction Timeliness:
transaction Shares: 25370
transaction Price Per Share: 0.00
transaction Acquired Disposed Code: A
id: F1
expiration Date: 2036-09-16
underlying Security Title: Common Stock
underlying Security Shares: 25370
shares Owned Following Transaction: 25370
direct Or Indirect Ownership: D
id: F2

Filing context

Quantities and prices are shown in the units filed. No trade value is inferred from their product.

Nagel Robert Thorvald: Director.

F1: The option vests in monthly increments over a period of one year from the grant date.

F2: The Reporting Person is a member of BVF Partners L.P. ("BVF") and is obligated to transfer the economic benefit, if any, received upon the sale of the shares issuable upon exercise of the equity grants to BVF. As such, the Reporting Person disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of his pecuniary interest therein, if any.